| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| 23andMe Holding Co. | Head of Therapeutics Discovery | Class A Common Stock | 573K | $204K | $0.36 | Aug 20, 2024 | Direct |
| 23andMe Holding Co. | Head of Therapeutics Discovery | Stock Option (Right to Buy) | 166K | Sep 15, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ME | 23andMe Holding Co. | Aug 20, 2024 | 1 | -$20.4K | 4 | Aug 21, 2024 | Head of Therapeutics Discovery |
| ME | 23andMe Holding Co. | May 20, 2024 | 1 | -$8.8K | 4 | May 21, 2024 | Head of Therapeutics Discovery |
| ME | 23andMe Holding Co. | Feb 20, 2024 | 1 | -$13.2K | 4 | Feb 21, 2024 | Head of Therapeutics Discovery |
| ME | 23andMe Holding Co. | Nov 20, 2023 | 1 | -$5.18K | 4 | Nov 21, 2023 | Head of Therapeutics Discovery |
| ME | 23andMe Holding Co. | Sep 15, 2023 | 3 | $0 | 4 | Sep 19, 2023 | Head of Therapeutics Discovery |
| ME | 23andMe Holding Co. | Sep 5, 2023 | 1 | -$2.74K | 4 | Sep 6, 2023 | Head of Therapeutics Discovery |
| ME | 23andMe Holding Co. | Aug 20, 2023 | 1 | -$9.33K | 4 | Aug 22, 2023 | Head of Therapeutics Discovery |
| ME | 23andMe Holding Co. | Aug 8, 2023 | 0 | $0 | 3 | Aug 11, 2023 | Head of Therapeutics Discovery |